In our current retrospective study, we investigated the expression patterns of SATB1 and p16 and their connection with clinicopathological data as well as their potential prognostic value in HL for the first time by means of immunohistochemical staining of paraffin-embedded lymph node biopsies from a single institution. The gene discussed is CDKN2A; the disease is Hodgkins lymphoma.